["{\"step_by_step_thinking\": \"Based on the provided documents, it can be inferred that ipratropium bromide (Atrovent) is a first-line therapy for patients with chronic obstructive pulmonary disease (COPD). The document also mentions that adding an inhaled beta agonist to the therapeutic regimen is reasonable for symptomatic patients who need quick relief. Therefore, the short-acting bronchodilator should be taken first to provide immediate relief and allow better deposition of other medications.\", \"answer_choice\": \"A\"}"]